Vaccine development inStaphylococcus aureus: taking the biofilm phenotype into consideration

Review of Meningococcal Group B Vaccines

(2010) Dan M. Granoff   CLINICAL INFECTIOUS DISEASES

Vaccine development inStaphylococcus aureus: taking the biofilm phenotype into consideration

(2010) Janette M. Harro et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Cholera vaccines for the developing world

(2010) Anna Lena Lopez et al.   Human vaccines & immunotherapeutics

Serogroup B meningococcal vaccines—an unfinished story

(2010) Manish Sadarangani et al.   LANCET INFECTIOUS DISEASES

Improved accuracy of cell surface shaving proteomics in Staphylococcus aureus using a false-positive control

(2010) Nestor Solis et al.   PROTEOMICS

Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance

(2009) M. M. Harriott et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants

(2009) T. Q. Zorzeto et al.   Clinical and Vaccine Immunology

Human Immune Proteome in Experimental Colonization with Staphylococcus aureus

(2009) S. Holtfreter et al.   Clinical and Vaccine Immunology

The role of polysaccharide intercellular adhesin (PIA) in Staphylococcus epidermidis adhesion to host tissues and subsequent antibiotic tolerance

(2009) A. R. Costa et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Immunological surrogate marker of rAls3p-N vaccine-induced protection againstStaphylococcus aureus: Table 1

(2009) Lin Lin et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection

(2009) Karen Smith Korsholm et al.   IMMUNOLOGY

Proteomics-Based Identification of Anchorless Cell Wall Proteins as Vaccine Candidates against Staphylococcus aureus

(2009) E. Glowalla et al.   INFECTION AND IMMUNITY

Streptococcus gordonii Modulates Candida albicans Biofilm Formation through Intergeneric Communication

(2009) C. V. Bamford et al.   INFECTION AND IMMUNITY

Synthetic  -(1->6)-Linked N-Acetylated and Nonacetylated Oligoglucosamines Used To Produce Conjugate Vaccines for Bacterial Pathogens

(2009) M. L. Gening et al.   INFECTION AND IMMUNITY

Host Defense and Pathogenesis in Staphylococcus aureus Infections

(2009) Frank R. DeLeo et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly- -1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation

(2009) A. H. K. Choi et al.   JOURNAL OF BACTERIOLOGY

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

(2009) A. M. Didierlaurent et al.   JOURNAL OF IMMUNOLOGY

The high-affinity phosphate transporter Pst in Proteus mirabilis HI4320 and its importance in biofilm formation

(2009) G. A. O'May et al.   MICROBIOLOGY-SGM

Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl β-1,6 glucosamine specific antibody production using biofilm-embedded bacteria

(2009) M.M. Pérez et al.   VACCINE

Advances in the development of next-generation anthrax vaccines

(2009) Arthur M. Friedlander et al.   VACCINE

c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection

(2009) Dong-Liang Hu et al.   VACCINE

Recombinant Mycobacterium bovis BCG

(2009) Reginaldo G. Bastos et al.   VACCINE

Genome-based approaches to develop vaccines against bacterial pathogens

(2009) Davide Serruto et al.   VACCINE

Effect of Conjugation with Polypeptide Carrier on the Enzymatic Degradation of Herpes Simplex Virus Glycoprotein D Derived Epitope Peptide

(2008) Regina Tugyi et al.   BIOCONJUGATE CHEMISTRY

Application of genomics in bacterial vaccine discovery: a decade in review

(2008) R ZAGURSKY et al.   CURRENT OPINION IN PHARMACOLOGY

The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus

(2008) B. Spellberg et al.   INFECTION AND IMMUNITY

Vaccination and passive immunisation against Staphylococcus aureus

(2008) Adam C. Schaffer et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rational design of nasal vaccines

(2008) Bram Slütter et al.   JOURNAL OF DRUG TARGETING

Vaccine protection againstStaphylococcus aureuspneumonia

(2008) Juliane Bubeck Wardenburg et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Developing Antibacterial Vaccines in Genomics and Proteomics Era

(2008) D. K. Kaushik et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

The role of microbiota in infectious disease

(2008) Bärbel Stecher et al.   TRENDS IN MICROBIOLOGY

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

(2008) Caroline L. Trotter et al.   VACCINE

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice

(2008) Andreas Wack et al.   VACCINE

Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections

(2008) Christopher D. Sibley et al.   PLoS Pathogens

What makes pathogens pathogenic

(2008) Garth D Ehrlich et al.   GENOME BIOLOGY